Postgraduate Medicine
Volume 132, 2020 - Issue 4
Open access
11,794
Views
12
CrossRef citations to date
0
Altmetric
Clinical focus: Diabetes - Original Research
Triple fixed-dose combination empagliflozin, linagliptin, and metformin for patients with type 2 diabetes
Ildiko Lingvaya Department of Internal Medicine/Endocrinology and Department of Population and Data Sciences, UT Southwestern Medical Center, Dallas, TX, USACorrespondence[email protected]
View further author information
, View further author information
Nadine Beetzb Global Clinical Operations, Early Trials, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riß, Germany
https://orcid.org/0000-0002-1071-7000View further author information
Regina Sennewaldb Global Clinical Operations, Early Trials, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riß, Germany
https://orcid.org/0000-0002-6499-0942View further author information
Annette Schuler-Metzc Translational Medicine and Clinical Pharmacology, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riß, Germany
https://orcid.org/0000-0002-0332-7709View further author information
Julia Bertulisc Translational Medicine and Clinical Pharmacology, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riß, Germany
https://orcid.org/0000-0002-4863-6003View further author information
Christina Loleyd Biostatistics and Data Sciences, Clinical Statistics, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riß, GermanyView further author information
, Benjamin Langd Biostatistics and Data Sciences, Clinical Statistics, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riß, GermanyView further author information
, Caroline Lippertc Translational Medicine and Clinical Pharmacology, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riß, GermanyView further author information
, Jisoo Leee Clinical Development & Cardiometabolism and Respiratory Medicine, Boehringer Ingelheim International GmbH, Ingelheim, GermanyView further author information
, Linda Shapiro Manningf Clinical Development & Medical Affairs - Cardiometabolism, Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, CT, USA
https://orcid.org/0000-0001-8229-381XView further author information
Derek Teradaf Clinical Development & Medical Affairs - Cardiometabolism, Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, CT, USAView further author information
show all
Pages 337-345
|
Received 05 Mar 2020, Accepted 30 Mar 2020, Published online: 04 May 2020
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.